ArticleBrazilian journal of veterinary medicine2025
Use of Oclacitinib in the treatment of pemphigus foliaceus in a dog: case report.
Article in Brazilian journal of veterinary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pemphigus foliaceus is an autoimmune bullous dermatosis caused by the action of antibodies against epidermal cells and is considered as the most frequent pemphigus complex disease that affects pets. It is characterized by the presence of intraepidermal pustules that may evolve into erosion, scaling, crusts, and alopecia, affecting the periocular area, nasal planum, ventral area, abdomen, and paw pads. The diagnosis is made by observing the animal's history, anamnesis, clinical signs, and laboratory tests such as cytological examination and is confirmed by histopathology. The recommended treatment is systemic immunosuppressive therapy, such as prednisone or prednisolone. This study reports the treatment of a male German Spitz canine with oral oclacitinib who was diagnosed with pemphigus foliaceus that was unresponsive to oral corticosteroids. Oclacitinib was effective in treating pemphigus foliaceus and may be a new therapeutic option for this dermatopathy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.